Current and new strategies in immunotherapy for superficial bladder cancer

Cancer statistics, 1999

1999 • 3,154 citations

The World Health Organization/International Society of Urological Pathology Consensus Classification of Urothelial (Transitional Cell) Neoplasms of the Urinary Bladder

1998 • 1,569 citations

Superficial Bladder Cancer: Progression and Recurrence

1983 • 947 citations

Prognostic Parameters in Superficial Bladder Cancer: An Analysis of 315 Cases

1982 • 434 citations

LONG-TERM RESULTS OF INTRAVESICAL THERAPY FOR SUPERFICIAL BLADDER CANCER

1992 • 285 citations

Bladder cancer clinical guidelines panel summary report on the management of nonmuscle invasive bladder cancer (stages Ta, T1 and TIS). The American Urological Association.

1999 • 217 citations

BLADDER CANCER CLINICAL GUIDELINES PANEL SUMMARY REPORT ON THE MANAGEMENT OF NONMUSCLE INVASIVE BLADDER CANCER (STAGES Ta, T1 AND TIS)

1999 • 189 citations

A Randomized Controlled Study of Intravesical α−2b-Interferon in Carcinoma in Situ of the Bladder

1990 • 171 citations

Alpha-interferon in superficial bladder cancer: a Northern California Oncology Group Study.

1988 • 154 citations

SALVAGE INTRAVESICAL THERAPY WITH INTERFERON-α2B PLUS LOW DOSE BACILLUS CALMETTE-GUERIN IS EFFECTIVE IN PATIENTS WITH SUPERFICIAL BLADDER CANCER IN WHOM BACILLUS CALMETTE-GUERIN ALONE PREVIOUSLY FAILED

2001 • 137 citations

Immunotherapy in Bladder Cancer with Keyhole-Limpet Hemocyanin: A Randomized Study

1988 • 110 citations

Superficial bladder cancer

2002 • 94 citations

Perioperative single dose instillation of epirubicin or interferon-alpha after transurethral resection for the prophylaxis of primary superficial bladder cancer recurrence: a prospective randomized multicenter study--FinnBladder III long-term results.

2002 • 84 citations

Phase 1 Study of the Intravesical Administration of Recombinant Human Interleukin-12 in Patients With Recurrent Superficial Transitional Cell Carcinoma of the Bladder

2003 • 76 citations

Keyhole Limpet Hemocyanin Immunotherapy of Bladder Cancer: Laboratory and Clinical Studies

2000 • 69 citations

Bacillus calmette-Guérin plus intravesical interferon alpha-2b in patients with superficial bladder cancer

1996 • 67 citations

Perioperative Single Dose Instillation of Epirubicin or Interferon-α After Transurethral Resection for The Prophylaxis of Primary Superficial Bladder Cancer Recurrence: A Prospective Randomized Multicenter Study—Finnbladder III Long-Term Results

2002 • 66 citations

Carcinoma in situ of the urinary bladder. Clues to host involvement in human carcinogenesis

1994 • 65 citations

INTRAVESICAL INTERLEUKIN-2 IN T1 PAPILLARY BLADDER CARCINOMA: REGRESSION OF MARKER LESION IN 8 OF 10 PATIENTS

1998 • 64 citations

Phase I clinical study of the recombinant oncotoxin TP40 in superficial bladder cancer.

1995 • 55 citations

Intravesical immunoprophylaxis in recurrent superficial bladder cancer (stage T1): Multicenter trial comparing bacille calmette-guérin and interferon-alpha

1997 • 54 citations

TRANSURETHRAL RESECTION WITH PERIOPERATIVE INSTILLATION OF INTERFERON-alpha OR EPIRUBICIN FOR THE PROPHYLAXIS OF RECURRENT PRIMARY SUPERFICIAL BLADDER CANCER: A PROSPECTIVE RANDOMIZED MULTICENTER STUDY-FINNBLADDER III

1999 • 54 citations

Prophylaxis of superficial bladder cancer with mitomycin or interferon alfa-2b: results of a multicentric Italian study.

1994 • 51 citations

Keyhole Limpet Hemocyanin for Carcinoma in situ of the Bladder: A Long-Term Follow-Up Study

2000 • 50 citations

Results at 43 months' follow-up of a doubleblind, randomized, prospective clinical trial using intravesical interferon alpha-2b in the prophylaxis of stage pt1 transitional cell carcinoma of the bladder

1997 • 39 citations

A controlled study of intravesical epirubicin with or without alpha2b‐interferon as prophylaxis for recurrent superficial transitional cell carcinoma of the bladder

1995 • 36 citations

A randomized comparative dose‐ranging study of interferon‐α and mitomycin‐C as an internal control in primary or recurrent superficial transitional cell carcinoma of the bladder

2002 • 35 citations

Results of a European Comparative Randomized Study Comparing Oral Bropirimine versus Intravesical BCG Treatment in BCG-Naive Patients with Carcinoma in situ of the Urinary Bladder

1999 • 34 citations

Antitumoral effect of recombinant mistletoe lectin on chemically induced urinary bladder carcinogenesis in a rat model

2001 • 33 citations

[BCG vs interferon A for prevention of recurrence of superficial bladder cancer. A prospective randomized study].

1994 • 31 citations

Antitumoral effects of an intravesically applied aqueous mistletoe extract on urinary bladder carcinoma MB49 in mice.

2000 • 25 citations

Local Immunotherapy of Superficial Bladder Cancer by Intravesical Instillation of Recombinant lnterleukin-2

1995 • 24 citations

Efficacy of escalating doses of intravesical interferon α‐2b in reducing recurrence rate and progression in superficial transitional cell carcinoma

1998 • 23 citations

Intravesical Recombinant Tumor Necrosis Factor in the Treatment of Superficial Bladder Cancer: An Eastern Cooperative Oncology Group Study

1995 • 22 citations

Treatment of Transitional Cell Carcinoma of the Bladder With Intravesical Interleukin-2: A Pilot Study

1993 • 21 citations

Intravesical Instillations of Interferon Gamma in the Prophylaxis of High Risk Superficial Bladder Cancer

2002 • 21 citations

How Effective is Topical Alpha‐2b Interferon in Preventing Recurrence of Superficial Bladder Cancer?

1991 • 20 citations

[Intravesical prevention of recurrence of superficial urinary bladder cancer with BCG and KLH. A prospective randomized study].

1991 • 20 citations

Immunostimulation in the urinary bladder by local application ofNocardia rubra cell wall skeleton preparation (Rubratin) for superficial bladder cancer immunotherapy — a phase I/II study

1997 • 20 citations

Interferon-α2b instillation prophylaxis in superficial bladder cancer—a prospective, controlled three-armed trial

1992 • 20 citations

Intravesical interferon treatment of superficial bladder cancer

1989 • 16 citations

Carcinoma in situ of the urinary bladder.

2007 • 15 citations

Interferon-alpha 2b instillation prophylaxis in superficial bladder cancer--a prospective, controlled three-armed trial. Project Group Bochum--Interferon and Superficial Bladder Cancer.

1992 • 14 citations

Intravesical Therapy of Superficial Bladder T ransitional Cell Carcinoma with Tumor Necrosis Factor-Alpha: Preliminary Report of a Phase I—II Study

1992 • 14 citations

[Topical immunotherapy (KLH) vs. chemotherapy (Ethoglucid) in prevention of recurrence of superficial bladder cancer. A prospective randomized study].

1994 • 12 citations

Prospective phase II trial of alternating intravesical Bacillus Calmette-Gu�rin (BCG) and Interferon alpha IIB in the treatment and prevention of superficial transitional cell carcinoma of the urinary bladder: Preliminary results

2000 • 12 citations

Treatment of Superficial Bladder Tumors with Intravesical Recombinant Interferon Alpha-2a

1988 • 12 citations

Combined Low-Dose Intravesical Immunotherapy (BCG + Interferon a-2b) in the Management of Superficial Transitional Cell Carcinoma of the Urinary Bladder: A Five-Year Follow-Up

2002 • 12 citations

Treatment of superficial bladder cancer with intravesical perfusion of rIL-2: a follow-up study.

1996 • 11 citations

Interferon alfa 2a in superficial bladder cancer prophylaxis: toleration and long-term follow-up. A phase I-II study.

1991 • 10 citations

Recombinant tumor necrosis factor for superficial bladder tumors

1992 • 9 citations

IS THERE A ROLE FOR RECOMBINANT TUMOR NECROSIS FACTOR ALPHA IN THE INTRAVESICAL TREATMENT OF SUPERFICIAL BLADDER TUMORS?—A PHASE II STUDY

1995 • 8 citations

Comparison of two doses of interferon-alpha-2b in intravesical prophylaxis of superficial bladder tumors. Portuguese Genito-Urinary Group.

1995 • 6 citations

[Late phase II clinical study for bropirimine (U-54461S) in situ carcinoma of the bladder: follow-up investigation. Bropirimine Study Group].

1999 • 1 citations